Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

키워드

참고문헌 (65)

1. Rinella ME, "Nonalcoholic fatty liver disease : a systematic review", JAMA, 313, pp.2263~2273 (2015)
2. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease : meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
3. Williams CD, "Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy : a prospective study", Gastroenterology, 140, pp.124~131 (2011)
4. Sesti G, "Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis", PLoS One, 9, pp.e104941~ (2014)
5. Charlton M, "Nonalcoholic fatty liver disease : a review of current understanding and future impact", Clin Gastroenterol Hepatol, 2, pp.1048~1058 (2004)
6. Farrell GC, "Nonalcoholic fatty liver disease : from steatosis to cirrhosis", Hepatology, 43(2 Suppl 1), pp.S99~S112 (2006)
7. Nalbantoglu IL, "Role of liver biopsy in nonalcoholic fatty liver disease", World J Gastroenterol, 20, pp.9026~9037 (2014)
8. Ratziu V, "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", Gastroenterology, 128, pp.1898~1906 (2005)
9. Sterling RK, "Development of a simple noninvasive index to predict significant fibrosis in patients with HIV", HCV coinfection, 2006, pp.43, 1317~1325
10. Angulo P, "The NAFLD fibrosis score : a noninvasive system that identifies liver fibrosis in patients with NAFLD", Hepatology, 45, pp.846~854 (2007)
11. Whiting P, "The development of QUADAS : a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews", BMC Med Res Methodol, 3, pp.25~ (2003)
12. Hayden JA, "Assessing bias in studies of prognostic factors", Ann Intern Med, 158, pp.280~286 (2013)
13. Aida Y, "Serum immunoreactive collagen IV detected by monoclonal antibodies as a marker of severe fibrosis in patients with non-alcoholic fatty liver disease", J Gastrointestin Liver Dis, 24, pp.61~68 (2015)
14. Anstee QM, "Noninvasive tests accurately identify advanced fibrosis due to NASH : baseline data from the STELLAR trials", Hepatology, 70, pp.1521~1530 (2019)
15. Balakrishnan M, "External validation of four point-of-care noninvasive scores for predicting advanced hepatic fibrosis in a predominantly Hispanic NAFLD population", Dig Dis Sci, 66, pp.2387~2393 (2021)
16. Boursier J, "New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD", J Hepatol, 71, pp.389~396 (2019)
17. Chan WK, "A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis", Hepatol Int, 9, pp.594~602 (2015)
18. Chan WK, "Optimizing use of nonalcoholic fatty liver disease fibrosis score, fibrosis-4 score, and liver stiffness measurement to identify patients with advanced fibrosis", Clin Gastroenterol Hepatol, 17, pp.2570~2580 (2019)
19. Cui J, "Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease : a prospective study", Aliment Pharmacol Ther, 41, pp.1271~1280 (2015)
20. Demir M, "NIKEI : a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD", PLoS One, 8, pp.e58360~ (2013)
21. de Carli MA, "Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease", Eur J Gastroenterol Hepatol, 32, pp.420~425 (2020)
22. Goh GB, "Clinical spectrum of non-alcoholic fatty liver disease in diabetic and nondiabetic patients", BBA Clin, 3, pp.141~145 (2014)
23. Joo SK, "Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease", Liver Int, 38, pp.331~341 (2018)
24. Jun DW, "External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients", J Gastroenterol Hepatol, 32, pp.1094~1099 (2017)
25. Kakisaka K, "Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease", J Gastroenterol, 53, pp.1285~1291 (2018)
26. Kao WY, "Fibroscan-based score to predict significant liver fibrosis in morbidly obese patients with nonalcoholic fatty liver disease", Obes Surg, 30, pp.1249~1257 (2020)
27. Eda Kaya, "Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease", Gut and Liver, 14(4), pp.486~491 (2020), 거트앤리버 소화기연관학회협의회[DOI]
28. Kim D, "Advanced fibrosis in nonalcoholic fatty liver disease : noninvasive assessment with MR elastography", Radiology, 268, pp.411~419 (2013)
29. Labenz C, "Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany", Aliment Pharmacol Ther, 48, pp.1109~1116 (2018)
30. Lang S, "Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools", Sci Rep, 10, pp.9385~ (2020)
31. Lum J, "Clinical profile of nonalcoholic fatty liver disease in nonobese patients", J Gastroenterol Hepatol, 36, pp.257~261 (2021)
32. McPherson S, "Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels", Eur J Gastroenterol Hepatol, 25, pp.652~658 (2013)
33. Meneses D, "Performance of noninvasive liver fibrosis scores in the morbid obese patient, same scores but different thresholds", Obes Surg, 30, pp.2538~2546 (2020)
34. Nasr P, "Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease", Scand J Gastroenterol, 51, pp.1126~1132 (2016)
35. Ooi GJ, "Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese", Obes Surg, 27, pp.115~125 (2017)
36. Patel YA, "Identifying nonalcoholic fatty liver disease advanced fibrosis in the Veterans Health Administration", Dig Dis Sci, 63, pp.2259~2266 (2018)
37. Pérez-Gutiérrez OZ, "Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population", Ann Hepatol, 12, pp.416~424 (2013)
38. Petta S, "The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease", Liver Int, 35, pp.1566~1573 (2015)
39. Petta S, "Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver disease", Am J Gastroenterol, 114, pp.916~928 (2019)
40. Siddiqui MS, "Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage", Clin Gastroenterol Hepatol, 17, pp.1877~1885 (2019)
41. Singh A, "Accuracy of noninvasive fibrosis scores to detect advanced fibrosis in patients with type-2 diabetes with biopsy-proven nonalcoholic fatty liver disease", J Clin Gastroenterol, 54, pp.891~897 (2020)
42. Treeprasertsuk S, "Accuracy of noninvasive scoring systems to assess advanced liver fibrosis in Thai patients with nonalcoholic fatty liver disease", Asian Biomed, 10, pp.s49~s55 (2016)
43. Wong VW, "Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis", Am J Gastroenterol, 103, pp.1682~1688 (2008)
44. Wong VW, "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", Hepatology, 51, pp.454~462 (2010)
45. Xun YH, "Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease", J Dig Dis, 13, pp.588~595 (2012)
46. Yang M, "Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease", J Gastrointestin Liver Dis, 28, pp.289~296 (2019)
47. Yoneda M, "Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels", J Gastroenterol, 48, pp.1051~1060 (2013)
48. Zhou YJ, "Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram", United European Gastroenterol J, 7, pp.1124~1134 (2019)
49. Xiao G, "Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease : a meta-analysis", Hepatology, 66, pp.1486~1501 (2017)
50. Sun W, "Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease : a meta-analysis study", Hepatol Res, 46, pp.862~870 (2016)
51. Jaruvongvanich V, "The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease : a systematic review and meta-analysis of cohort study", Clin Res Hepatol Gastroenterol, 41, pp.629~634 (2017)
52. Bril F, "Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD", J Clin Endocrinol Metab, 101, pp.644~652 (2016)
53. Vilar-Gomez E, "Non-invasive assessment of non-alcoholic fatty liver disease : clinical prediction rules and blood-based biomarkers", J Hepatol, 68, pp.305~315 (2018)
54. Sonneveld MJ, "Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B : results from the SONIC-B study", Lancet Gastroenterol Hepatol, 4, pp.538~544 (2019)
55. Vallet-Pichard A, "FIB-4 : an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest", Hepatology, 46, pp.32~36 (2007)
56. Imajo K, "Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography", Gastroenterology, 150, pp.626~637 (2016)
57. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
58. European Association for the Study of the Liver (EASL), "EASLEASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease", Obes Facts, 9, pp.65~90 (2016)
59. Chalasani N, "The diagnosis and management of non-alcoholic fatty liver disease : practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology", Gastroenterology, 142, pp.1592~1609 (2012)
60. Mózes FE, "Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis", Gut, 71, pp.1006~1019 (2022)
61. McPherson S, "Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease", Gut, 59, pp.1265~1269 (2010)
62. Torriani FJ, "Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients", N Engl J Med, 351, pp.438~450 (2004)
63. Srivastava A, "Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease", BMC Gastroenterol, 19, pp.122~ (2019)
64. Salva-Pastor N, "The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease : role of the primary care provider", Gastroenterol Hepatol Bed Bench, 12, pp.267~277 (2019)
65. Tapper EB, "Simple non-invasive biomarkers of advanced fibrosis in the evaluation of nonalcoholic fatty liver disease", Gastroenterol Rep(Oxf), 2, pp.276~280 (2014)

관련 논문AI추천